Loading...
XKRX
000220
Market cap45mUSD
Oct 08, Last price  
3,840.00KRW
1D
0.00%
1Q
2.54%
Jan 2017
-17.33%
Name

Yuyu Pharma Inc

Chart & performance

D1W1MN
XKRX:000220 chart
P/E
7.42
P/S
0.43
EPS
517.80
Div yield, %
2.99%
Shrs. gr., 5y
6.29%
Rev. gr., 5y
7.50%
Revenues
140.88b
+5.81%
73,393,135,00073,840,117,00045,014,225,00047,900,307,00052,027,334,00058,798,714,33061,984,734,47061,994,114,84062,816,222,71069,743,374,56071,578,932,06062,852,074,31083,096,445,25090,877,644,15098,119,846,400115,655,485,000138,881,056,340137,209,588,670133,147,218,000140,884,667,000
Net income
8.15b
-6.49%
8,558,432,00013,566,114,000-5,687,375,0002,273,392,0001,117,272,0001,906,768,9002,978,726,7901,876,521,870-7,467,373,380-252,675,0805,885,697,4304,541,420,8104,020,291,0704,722,296,7102,412,605,440-920,289,070-4,425,392,920-7,180,899,6688,720,351,0008,154,030,000
CFO
16.07b
-35.61%
6,801,053,0003,263,836,00013,074,087,0009,407,251,0005,814,628,0006,673,925,2006,510,487,490-775,171,8001,363,384,420-11,683,508,1609,816,265,2901,335,382,2606,110,025,07013,185,371,370-2,669,008,8204,508,660,900-6,229,000,580420,857,13024,950,108,00016,066,615,000
Dividend
Dec 29, 2025115 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Yuyu Pharma, Inc. is dedicated to the development and commercialization of a wide spectrum of pharmaceutical products. Its comprehensive collection of prescription medications spans numerous therapeutic categories, offering treatments for conditions such as osteoporosis, disorders affecting brain and bone metabolism (including hypocalcemia), central and peripheral circulatory impairments, thromboembolism, respiratory issues, high blood pressure, pulmonary tuberculosis, arthritis, diabetic neuropathy, and eczematous dermatitis. The company further supplies other cardiovascular agents, antibiotics, and skeletal muscle relaxants. Beyond its prescription offerings, Yuyu Pharma also produces over-the-counter drugs and various health supplements. Originally established in 1941 as YuYu Inc., the company adopted its current name, Yuyu Pharma, Inc., in May 2008, and its corporate headquarters are located in Seoul, South Korea.

Key people

Ji Hun Bae
Assistant Managing Director
Jun Hui Cheon
Assistant Managing Director
Laxmikant Gharat
Assistant Managing Director
Jae Won Jang
Assistant Managing Director
Gyeong Won Kim
Assistant Managing Director
Chang Yun Lee
Assistant Managing Director
Seung Pyo Woo
Assistant Managing Director
Chae Yeong Yim
Assistant Managing Director
No Yong Park
Co-Chief Executive Officer, Director · since 2023
Won Sang Yoo
President, Co-Chief Executive Officer, Director · since 2023
Gang Seok Choi
Non-Executive Independent Director · since 2025
Sang Eon Joo
Non-Executive Independent Director · since 2022
Seung Wu Lee
Non-Executive Independent Director
IPO date
Nov 18, 1975
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT